Description
MEDICAL, DENTAL & VETERINARY EQUIPMENT & SUPPLIES
First action · last action
2009-11-24 · 2009-11-24
Transactions
1
First transaction's obligation
$6,091
Base + all options value (sum of deltas)
$6,091
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5478X
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-11-24+$6,091= $6,091
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-11-24 | +$6,091 | $6,091 | MEDICAL, DENTAL & VETERINARY EQUIPMENT & SUPPLIES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NH3LDK8CFAK7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N1004 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $187,594 | FY2026 |
| 36C24426N1005 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $395,322 | FY2026 |
| 36C24426N1001 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $431,969 | FY2026 |
| 36C24426N1003 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $267,954 | FY2026 |
| 36C24426N1002 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $607,544 | FY2026 |
| 36C24426N1006 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $783,641 | FY2026 |
Other recipients under 6505 from 623S-MUSKOGEE SMALL PURCHASE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| V623P00813 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 623S-MUSKOGEE SMALL PURCHASE | $4,339 | FY2010 |
| V623A00064 | APHENA PHARMA SOLUTIONS-TENNESSEE, LLC | 623S-MUSKOGEE SMALL PURCHASE | $4,425 | FY2010 |
| V623P00630 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 623S-MUSKOGEE SMALL PURCHASE | $5,871 | FY2010 |
| V623A00024 | APHENA PHARMA SOLUTIONS-TENNESSEE, LLC | 623S-MUSKOGEE SMALL PURCHASE | $3,500 | FY2010 |
| V623P00143 | BAYER PHARMACEUTICALS CORPORATION | 623S-MUSKOGEE SMALL PURCHASE | $5,834 | FY2010 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_V623P00351_3600_V797P5478X_3600 · retrieved 2026-09-26.